• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

E6癌蛋白的结构与功能分析:对人乳头瘤病毒介导的发病机制分子途径的见解

Structural and functional analysis of E6 oncoprotein: insights in the molecular pathways of human papillomavirus-mediated pathogenesis.

作者信息

Nominé Yves, Masson Murielle, Charbonnier Sebastian, Zanier Katia, Ristriani Tutik, Deryckère François, Sibler Annie-Paule, Desplancq Dominique, Atkinson Robert Andrew, Weiss Etienne, Orfanoudakis Georges, Kieffer Bruno, Travé Gilles

机构信息

Equipe Oncoprotéine, UMR CNRS 7100, Ecole Supérieure de Biotechnologie de Strasbourg, Boulevard Sebastien Brant, BP 10413, 67412 Illkirch Cedex, France.

出版信息

Mol Cell. 2006 Mar 3;21(5):665-78. doi: 10.1016/j.molcel.2006.01.024.

DOI:10.1016/j.molcel.2006.01.024
PMID:16507364
Abstract

Oncoprotein E6 is essential for oncogenesis induced by human papillomaviruses (HPVs). The solution structure of HPV16-E6 C-terminal domain reveals a zinc binding fold. A model of full-length E6 is proposed and analyzed in the context of HPV evolution. E6 appears as a chameleon protein combining a conserved structural scaffold with highly variable surfaces participating in generic or specialized HPV functions. We investigated surface residues involved in two specialized activities of high-risk genital HPV E6: p53 tumor suppressor degradation and nucleic acid binding. Screening of E6 surface mutants identified an in vivo p53 degradation-defective mutant that fails to recruit p53 to ubiquitin ligase E6AP and restores high p53 levels in cervical carcinoma cells by competing with endogeneous E6. We also mapped the nucleic acid binding surface of E6, the positive potential of which correlates with genital oncogenicity. E6 structure-function analysis provides new clues for understanding and counteracting the complex pathways of HPV-mediated pathogenesis.

摘要

癌蛋白E6对于人乳头瘤病毒(HPV)诱导的肿瘤发生至关重要。HPV16-E6 C末端结构域的溶液结构揭示了一种锌结合折叠。提出了全长E6的模型,并在HPV进化的背景下进行了分析。E6表现为一种变色龙蛋白,它结合了保守的结构支架和参与一般或特殊HPV功能的高度可变表面。我们研究了与高危生殖器HPV E6的两种特殊活性相关的表面残基:p53肿瘤抑制因子降解和核酸结合。对E6表面突变体的筛选鉴定出一种体内p53降解缺陷型突变体,该突变体无法将p53募集到泛素连接酶E6AP,并通过与内源性E6竞争来恢复宫颈癌细胞中的高p53水平。我们还绘制了E6的核酸结合表面,其正电位与生殖器致癌性相关。E6结构-功能分析为理解和对抗HPV介导的发病机制的复杂途径提供了新线索。

相似文献

1
Structural and functional analysis of E6 oncoprotein: insights in the molecular pathways of human papillomavirus-mediated pathogenesis.E6癌蛋白的结构与功能分析:对人乳头瘤病毒介导的发病机制分子途径的见解
Mol Cell. 2006 Mar 3;21(5):665-78. doi: 10.1016/j.molcel.2006.01.024.
2
Specific recognition of four-way DNA junctions by the C-terminal zinc-binding domain of HPV oncoprotein E6.人乳头瘤病毒癌蛋白E6的C端锌结合结构域对四链DNA连接体的特异性识别
J Mol Biol. 2001 Jan 26;305(4):729-39. doi: 10.1006/jmbi.2000.4330.
3
A single-codon mutation converts HPV16 E6 oncoprotein into a potential tumor suppressor, which induces p53-dependent senescence of HPV-positive HeLa cervical cancer cells.单密码子突变可将人乳头瘤病毒16型(HPV16)E6癌蛋白转化为一种潜在的肿瘤抑制因子,该因子可诱导HPV阳性的人宫颈癌HeLa细胞发生p53依赖性衰老。
Oncogene. 2009 Feb 5;28(5):762-72. doi: 10.1038/onc.2008.422. Epub 2008 Nov 17.
4
HPV oncoprotein E6 is a structure-dependent DNA-binding protein that recognizes four-way junctions.人乳头瘤病毒癌蛋白E6是一种依赖结构的DNA结合蛋白,可识别四链连接点。
J Mol Biol. 2000 Mar 10;296(5):1189-203. doi: 10.1006/jmbi.2000.3527.
5
Mutational analysis of human papillomavirus type 16 E6 protein: transforming function for human cells and degradation of p53 in vitro.人乳头瘤病毒16型E6蛋白的突变分析:对人细胞的转化功能及体外p53降解
Virology. 1995 Oct 1;212(2):535-42. doi: 10.1006/viro.1995.1511.
6
Targetting of the N-terminal domain of the human papillomavirus type 16 E6 oncoprotein with monomeric ScFvs blocks the E6-mediated degradation of cellular p53.用单体单链抗体片段靶向人乳头瘤病毒16型E6癌蛋白的N端结构域可阻断E6介导的细胞p53降解。
J Mol Recognit. 1999 Mar-Apr;12(2):141-52. doi: 10.1002/(SICI)1099-1352(199903/04)12:2<141::AID-JMR453>3.0.CO;2-O.
7
Mutational analysis of HPV-18 E6 identifies domains required for p53 degradation in vitro, abolition of p53 transactivation in vivo and immortalisation of primary BMK cells.人乳头瘤病毒18型E6基因的突变分析确定了体外p53降解、体内p53反式激活作用的消除以及原代BMK细胞永生化所需的结构域。
Oncogene. 1994 Jul;9(7):1869-76.
8
Mechanism of HPV E6 proteins in cellular transformation.人乳头瘤病毒E6蛋白在细胞转化中的机制。
Semin Cancer Biol. 1996 Dec;7(6):317-26. doi: 10.1006/scbi.1996.0041.
9
The domain of p53 required for binding HPV 16 E6 is separable from the degradation domain.与HPV 16 E6结合所需的p53结构域与降解结构域是可分离的。
Oncogene. 1995 Feb 2;10(3):457-65.
10
HPV-18 E6*I protein modulates the E6-directed degradation of p53 by binding to full-length HPV-18 E6.人乳头瘤病毒18型E6*I蛋白通过与全长人乳头瘤病毒18型E6结合,调节E6介导的p53降解。
Oncogene. 1999 Dec 9;18(52):7403-8. doi: 10.1038/sj.onc.1203134.

引用本文的文献

1
Structural engineering of stabilized, expanded epitope nanoparticle vaccines for HPV.用于人乳头瘤病毒(HPV)的稳定、扩展表位纳米颗粒疫苗的结构工程
Front Immunol. 2025 Jan 31;16:1535261. doi: 10.3389/fimmu.2025.1535261. eCollection 2025.
2
Too many cooks in the kitchen: HPV driven carcinogenesis - The result of collaboration or competition?厨房里厨师太多:人乳头瘤病毒驱动的致癌作用——协作还是竞争的结果?
Tumour Virus Res. 2024 Dec 27;19:200311. doi: 10.1016/j.tvr.2024.200311.
3
Cysteine-Specific Multifaceted Bioconjugation of Peptides and Proteins Using 5-Substituted 1,2,3-Triazines.
使用 5-取代的 1,2,3-三嗪对肽和蛋白质进行半胱氨酸特异性多方面生物偶联。
Adv Sci (Weinh). 2024 Jun;11(21):e2308491. doi: 10.1002/advs.202308491. Epub 2024 Mar 11.
4
Structure of the p53 degradation complex from HPV16.HPV16 型 p53 降解复合物的结构。
Nat Commun. 2024 Feb 28;15(1):1842. doi: 10.1038/s41467-024-45920-w.
5
In-Silico Molecular Modeling Studies to Identify Novel Potential Inhibitors of HPV E6 Protein.用于鉴定人乳头瘤病毒E6蛋白新型潜在抑制剂的计算机分子模拟研究
Vaccines (Basel). 2022 Sep 2;10(9):1452. doi: 10.3390/vaccines10091452.
6
Deciphering the mechanisms of HPV E6 mutations in the destabilization of E6/E6AP/p53 complex.解析 HPV E6 突变在 E6/E6AP/p53 复合物失稳中的作用机制。
Biophys J. 2022 May 3;121(9):1704-1714. doi: 10.1016/j.bpj.2022.03.030. Epub 2022 Mar 29.
7
Non-human primate papillomavirus E6-mediated p53 degradation reveals ancient evolutionary adaptation of carcinogenic phenotype to host niche.非人类灵长类动物乳头瘤病毒 E6 介导的 p53 降解揭示了致癌表型对宿主小生境的古老进化适应。
PLoS Pathog. 2022 Mar 25;18(3):e1010444. doi: 10.1371/journal.ppat.1010444. eCollection 2022 Mar.
8
Peptide-Based Nanovaccines in the Treatment of Cervical Cancer: A Review of Recent Advances.基于肽的纳米疫苗在宫颈癌治疗中的应用:研究进展综述。
Int J Nanomedicine. 2022 Feb 25;17:869-900. doi: 10.2147/IJN.S269986. eCollection 2022.
9
Construction and immune effect of an HPV16/18/58 trivalent therapeutic adenovirus vector vaccine.人乳头瘤病毒16/18/58三价治疗性腺病毒载体疫苗的构建及免疫效果
Infect Agent Cancer. 2022 Feb 23;17(1):5. doi: 10.1186/s13027-022-00417-3.
10
Human Papillomaviruses as Infectious Agents in Gynecological Cancers. Oncogenic Properties of Viral Proteins.人乳头瘤病毒作为妇科癌症的传染性病原体。病毒蛋白的致癌特性。
Int J Mol Sci. 2022 Feb 5;23(3):1818. doi: 10.3390/ijms23031818.